CNS Pharmaceuticals Inc CNSP
$5.82
▲ +19.94%
(+$0.97)
⬆️ Above Yest. High
🎈 Low Float
🗓️ Earnings Next Week
Open
$4.81
Prev Close
$4.85
Day Range
$4.81 – $5.82
52W Range
$1.90 – $10.59
Market Cap
$8.50M
Beta
1.02
EPS (TTM)
$-29.17
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2019-11-08 |
| Shares Out. | 1,460,000 |
| Website | cnspharma.com/ ↗ |
| Phone | 18009469185 |
| Employees | 8 |
| Net Income | -$4.9M |
| Free Cash Flow | -$15.2M |
| Total Assets | $4.7M |
| Total Liabilities | $4.6M |
| Equity | $70,705 |
About CNS Pharmaceuticals Inc
CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.
CNS Pharmaceuticals Inc is a publicly traded company under the ticker symbol CNSP on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
7 analysts (2026-07-01)